To investigate whether CCN1 expression was altered in patients with NASH, we detected its expression level by ELISA in the serum of patients with NASH (n = 22) and healthy controls (HC, n = 22). The gene discussed is CCN1; the disease is metabolic dysfunction-associated steatohepatitis.